Please login to read the full article.
Scrip Regulatory Affairs
Commission clarifies IVD classification and borderline issues in revised EU guideline
09 February 2012
Vibha Sharma
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- European Commission issues much-awaited guide on regulating standalone software as medical devices/IVDs
- EMA's ATMP classification proposals out for consultation
- EU Commission proposes clinical evidence requirements for all IVDs except lowest-risk
- Early 2012 publication possible for much-needed EU software guidance
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
